KEAP1 and cancer: NQO1’s induction is driven by transcriptional activation through the Keap1/Nrf2 pathway, which is frequently dysregulated in cancer cells.9–12 The heightened NQO1 levels in cancer cells confer a survival advantage by enabling better oxidative stress management, facilitating tumor growth, and potentially contributing to treatment resistance.13–15